Genome games: A secret meet and a controversy
By Pete Shanks,
Deccan Chronicle
| 05. 22. 2016
On May 10, about 130 scientists, entrepreneurs and others held an invitation-only event at Harvard. Organisers told invitees not to talk to the press and not to discuss pending publications related to the topic they were there to discuss. Wait, what? Were they afraid of public panic? Was an asteroid on its way to destroy Earth? Was a catastrophic virus on the loose?
No, they were discussing future research, and how to get a lot more money for it. But they knew that if word got out people might be upset. Because they discussed building a completely synthetic version of a human genome. Not actually artificial people, but a huge step forward in synthetic biology. One of those invited, Drew Endy, a Stanford professor who is one of the leaders in the field, not only refused to come but tweeted: “If you need secrecy to discuss your proposed research (synthesizing a human genome) you are doing something wrong.”
Private water-cooler chat is certainly one way that ideas are developed. But over 100 people flown in from around the country —...
Related Articles
By Jonathan D. Grinstein, Genetic Engineering & Biotechnology News | 06.26.2024
Partial screenshot from The Bridge Recombination Mechanism
video by The Arc Institute on YouTube (CC)
Buried in a family of mobile genetic elements, Arc Institute researchers led by Patrick Hsu, PhD, have discovered an RNA-guided system that enables modular...
By Carl Zimmer, The New York Times | 05.31.2024
Last year, Jaume Pellicer led a team of fellow scientists into a forest on Grande Terre, an island east of Australia. They were in search of a fern called Tmesipteris oblanceolata. Standing just a few inches tall, it was not...
By Liz Szabo, The New York Times | 05.29.2024
By the time Rena Barrow-Wells gave birth to her fourth baby in 2020, she was well-versed in caring for a child with cystic fibrosis. She was also experienced in fighting for a diagnosis of the disease, which runs in families...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...